Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock
- PMID: 30335688
- DOI: 10.1097/PEC.0000000000001638
Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock
Abstract
Vascular endothelial growth factor (VEGF) and its receptor, soluble fms-like tyrosine kinase (sFLT), are biomarkers of endothelial activation. Vascular endothelial growth factor and sFLT have been associated with sepsis severity among adults, but pediatric data are lacking. The goal of this study was to assess VEGF and sFLT as predictors of outcome for children with sepsis.
Methods: Biomarkers measured for each patient at time of presentation to the emergency department were compared in children with septic shock versus children with sepsis without shock. For children with septic shock, the associations between biomarker levels and clinical outcome measures, including intensive care unit and hospital length of stay, vasoactive inotrope score, and measures of organ dysfunction, were assessed.
Results: Soluble fms-like tyrosine kinase and VEGF were elevated in children with septic shock (n = 73) compared with those with sepsis (n = 93). Elevated sFLT but not VEGF was associated with longer intensive care unit length of stay (P = 0.003), longer time requiring vasoactive agents (P < 0.001), higher maximum vasoactive inotrope score (P < 0.001), and higher maximum pediatric logistic organ dysfunction score (P < 0.001).
Conclusions: Vascular endothelial growth factor and sFLT measured in the emergency department are elevated in children with septic shock, and elevated sFLT but not VEGF is associated with worse clinical outcomes.
Similar articles
-
Value of the biomarker soluble tyrosine kinase 1 type fms (sFLT-1) in the diagnosis and prognosis of sepsis: a systematic review.Med Clin (Barc). 2024 Sep 13;163(5):224-231. doi: 10.1016/j.medcli.2024.03.027. Epub 2024 Jun 8. Med Clin (Barc). 2024. PMID: 38851948 English, Spanish.
-
Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study.J Transl Med. 2011 Mar 3;9:23. doi: 10.1186/1479-5876-9-23. J Transl Med. 2011. PMID: 21371321 Free PMC article.
-
A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis.Shock. 2008 Apr;29(4):452-7. doi: 10.1097/shk.0b013e31815072c1. Shock. 2008. PMID: 18598002 Free PMC article.
-
Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial.Chest. 2017 Jul;152(1):22-31. doi: 10.1016/j.chest.2017.01.010. Epub 2017 Jan 19. Chest. 2017. PMID: 28109962 Free PMC article. Clinical Trial.
-
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].Nephrol Ther. 2019 Nov;15(6):413-429. doi: 10.1016/j.nephro.2018.10.005. Epub 2019 Mar 30. Nephrol Ther. 2019. PMID: 30935786 Review. French.
Cited by
-
Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.Crit Care Med. 2020 Mar;48(3):344-352. doi: 10.1097/CCM.0000000000004091. Crit Care Med. 2020. PMID: 32058372 Free PMC article.
-
Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome.Crit Care Explor. 2020 Dec 4;2(12):e0295. doi: 10.1097/CCE.0000000000000295. eCollection 2020 Dec. Crit Care Explor. 2020. PMID: 33299985 Free PMC article.
-
Prognostic role of elevated VEGF in sepsis: A systematic review and meta-analysis.Front Physiol. 2022 Jul 22;13:941257. doi: 10.3389/fphys.2022.941257. eCollection 2022. Front Physiol. 2022. PMID: 35936894 Free PMC article.
-
Genetic polymorphisms, biomarkers and signaling pathways associated with septic shock: from diagnosis to therapeutic targets.Burns Trauma. 2024 May 6;12:tkae006. doi: 10.1093/burnst/tkae006. eCollection 2024. Burns Trauma. 2024. PMID: 38716051 Free PMC article. Review.
-
Umbilical Cord-Derived CD362+ Mesenchymal Stromal Cells Attenuate Polymicrobial Sepsis Induced by Caecal Ligation and Puncture.Int J Mol Sci. 2020 Nov 4;21(21):8270. doi: 10.3390/ijms21218270. Int J Mol Sci. 2020. PMID: 33158246 Free PMC article.
References
-
- Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167:695–701.
-
- De Backer D, Orbegozo Cortes D, Donadello K, et al. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5:73–79.
-
- Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–1309.
-
- Pickkers P, Sprong T, Eijk L, et al. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock. 2005;24:508–512.
-
- van der Flier M, van Leeuwen HJ, van Kessel KP, et al. Plasma vascular endothelial growth factor in severe sepsis. Shock. 2005;23:35–38.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous